1. History of HTA: introduction;Banta;International Journal of Technology Assessment,2009
2. Generating health technology assessment evidence for rare diseases;Facey;International Journal of Technology Assessment,2014
3. Institute for Quality and Efficacy in Healthcare (IQWiG). What type of evidence is currently being considered in the development of clinical practice guidelines for rare diseases? (English translation of executive summary). Cologne; 2011. Available at: http://portal.dimdi.de/de/hta/hta_berichte/hta321_abstract_en.pdf, [Accessed 15 May 2016].
4. European Commission, DG., Health and Food Safety. Rare diseases, policy. 2015. Available at: http://ec.europa.eu/health/rare_diseases/policy/index_en.htm, [Accessed 15 May 2016].
5. Assessing the economic challenges posed by orphan drugs;Drummond;Int J Technol Assess,2007